SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ELBIT MEDICAL IMAGING - EMITF - U.S. OTC -- Ignore unavailable to you. Want to Upgrade?

To: voodooist who wrote (74)9/13/1998 2:35:00 PM
From: voodooist  Respond to of 79
 
Results of Sunday trading in Israel: EMITF up 26.2%, ELRNF up 8.7%, and even ESLTF and ELBTF were up 4-5%, with GLOBES citing takeover speculation on ESLTF (by Tadiran). Globes claims that the "true" value of ELT and EMITF will be determined during US trading on Monday.



To: voodooist who wrote (74)9/13/1998 7:26:00 PM
From: MUDMAN  Read Replies (1) | Respond to of 79
 
According to the hotline, the proceeds are worth $23/share for Elscint. After tax, net proceeds are figured to be in the range of $16 to $20 per share. No mention of ESLTF on the hotline. Mudman


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News